In this study, we hypothesized that the biomarkers for pulmonary fibrosis, surfactant protein D (SP-D), and KL-6 would serve as good indicators of fibrotic lesions in CPFE. The gene discussed is MUC1; the disease is combined pulmonary fibrosis-emphysema syndrome.